+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anticoccidial Drugs - Global Strategic Business Report

  • PDF Icon

    Report

  • 162 Pages
  • June 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 6069517
Description Jump to:
The global market for Anticoccidial Drugs was estimated at US$203.1 Million in 2024 and is projected to reach US$254.6 Million by 2030, growing at a CAGR of 3.8% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Anticoccidial Drugs market.

Global Anticoccidial Drugs Market - Key Trends & Drivers Summarized

What is Fueling the Demand for Anticoccidial Drugs Worldwide?

Coccidiosis remains a persistent threat to livestock, particularly in poultry and cattle, causing significant economic losses due to morbidity, mortality, and decreased productivity. The growing global demand for protein-rich foods, such as chicken and eggs, has heightened the need for effective anticoccidial drugs. Large-scale poultry farming operations rely heavily on prophylactic and therapeutic anticoccidials to maintain herd health and prevent outbreaks. Additionally, with emerging strains of Eimeria parasites displaying resistance to traditional treatments, there is an increasing focus on developing new-generation drugs with enhanced efficacy and reduced resistance profiles. The market is also experiencing a shift towards combination therapies that integrate ionophores and synthetic anticoccidials to optimize parasite control while minimizing drug resistance.

How is Regulatory Pressure Reshaping the Anticoccidial Market?

Stringent regulations governing the use of antibiotics and medicated feed additives in animal husbandry have significantly influenced the dynamics of the anticoccidial drugs market. Governments and regulatory agencies, including the FDA and the European Medicines Agency (EMA), are enforcing strict guidelines on the use of anticoccidials to mitigate antimicrobial resistance (AMR) risks. This has led to the phasing out of certain traditional drugs, compelling pharmaceutical companies to develop alternative, non-antibiotic coccidiosis control solutions. Consequently, the industry is witnessing an increased adoption of vaccines and phytogenic feed additives, alongside a rising demand for novel anticoccidial formulations that align with regulatory compliance while ensuring sustainable livestock production.

What Role Does Technological Innovation Play in Market Evolution?

The anticoccidial drugs market is undergoing a technological transformation with advancements in drug formulation, delivery mechanisms, and precision livestock farming. New drug molecules with improved pharmacokinetics and targeted action are being developed to enhance treatment outcomes while reducing toxicity risks. Nanotechnology is also gaining traction, enabling better drug absorption and sustained release for prolonged efficacy. Additionally, the integration of artificial intelligence (AI) and big data analytics in disease surveillance is empowering farmers with real-time insights to implement timely and effective coccidiosis management strategies. These innovations are not only optimizing drug efficacy but also contributing to cost-effective and environmentally sustainable livestock rearing practices.

What Are the Key Growth Drivers Accelerating the Market Expansion?

The growth in the global anticoccidial drugs market is driven by several factors, including the rising demand for high-quality animal protein, increasing livestock production, and the expansion of commercial poultry farms. Rapid urbanization and evolving dietary preferences, particularly in emerging economies, are further amplifying the need for effective disease control measures in livestock. Additionally, advancements in veterinary pharmaceuticals and the introduction of novel drug formulations are expanding the treatment landscape. The shift towards integrated coccidiosis management, incorporating vaccination, biosecurity, and novel feed additives, is also fueling market growth. Furthermore, strategic collaborations between pharmaceutical companies and research institutions to develop next-generation anticoccidials are poised to drive sustained industry expansion in the coming years.

Scope of Study:

The report analyzes the Anticoccidial Drugs market in terms of units by the following Segments, and Geographic Regions/Countries:
  • Segments: Drug Class (Synthetic Drugs, Ionophore Drugs); Drug Action (Coccidiostatic Action, Coccidiocidal Action); Animal Type (Companion Animals, Livestock Animals);
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Synthetic Drugs segment, which is expected to reach US$148.1 Million by 2030 with a CAGR of a 4.5%. The Ionophore Drugs segment is also set to grow at 2.9% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $53.4 Million in 2024, and China, forecasted to grow at an impressive 3.8% CAGR to reach $41.1 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Anticoccidial Drugs Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Anticoccidial Drugs Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Anticoccidial Drugs Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Biochem Pharmaceuticals, Boehringer Ingelheim Animal Health USA Inc., Ceva Sante Animale, Elanco Animal Health Incorporated, HIPRA SA and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 36 companies featured in this Anticoccidial Drugs market report include:

  • Biochem Pharmaceuticals
  • Boehringer Ingelheim Animal Health USA Inc.
  • Ceva Sante Animale
  • Elanco Animal Health Incorporated
  • HIPRA SA
  • Huvepharma
  • Impextraco NV
  • Merck & Co., Inc. - MSD Animal Health
  • Phibro Animal Health Corporation
  • Vetoquinol India Animal Health Pvt Ltd
  • VIRBAC Animal Health India Private Ltd.
  • Zoetis India Ltd

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

  • Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
  • Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
  • Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
  • Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
  • Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
  • Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
  • Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Anticoccidial Drugs - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Demand for Poultry and Livestock Disease Prevention Driving Market Growth
Expansion of Intensive Animal Farming Increasing the Need for Anticoccidial Agents
Rising Adoption of Ionophores and Non-Ionophore Anticoccidials in Feed Additives
Increasing Focus on Sustainable and Antibiotic-Free Coccidiosis Prevention
Surge in Development of Next-Generation Vaccines as Alternatives to Drugs
Expansion of Integrated Farm Management Practices Enhancing Drug Efficacy
Growing Investments in Herbal and Natural Anticoccidial Solutions
Increasing Demand for Combination Therapies for Enhanced Parasite Control
Advancements in Genomic Research for Targeted Coccidiosis Treatment
Rising Consumer Demand for Organic Meat Driving Shift Towards Natural Solutions
Expansion of Anticoccidial Drug Use in Companion Animals and Exotic Species
Growing Strategic Partnerships for Global Distribution of Anticoccidial Drugs
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Anticoccidial Drugs Market Analysis of Annual Sales in US$ for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Anticoccidial Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 3: World 6-Year Perspective for Anticoccidial Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Synthetic Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 5: World 6-Year Perspective for Synthetic Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 6: World Recent Past, Current & Future Analysis for Ionophore Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 7: World 6-Year Perspective for Ionophore Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Coccidiostatic Action by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 9: World 6-Year Perspective for Coccidiostatic Action by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Coccidiocidal Action by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 11: World 6-Year Perspective for Coccidiocidal Action by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 12: World Recent Past, Current & Future Analysis for Companion Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 13: World 6-Year Perspective for Companion Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Livestock Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 15: World 6-Year Perspective for Livestock Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 16: USA Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 17: USA 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
TABLE 18: USA Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 19: USA 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
TABLE 20: USA Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 21: USA 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
CANADA
TABLE 22: Canada Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 23: Canada 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
TABLE 24: Canada Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 25: Canada 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
TABLE 26: Canada Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 27: Canada 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
JAPAN
Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 28: Japan Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 29: Japan 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
TABLE 30: Japan Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 31: Japan 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
TABLE 32: Japan Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 33: Japan 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
CHINA
Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 34: China Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 35: China 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
TABLE 36: China Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 37: China 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
TABLE 38: China Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 39: China 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
EUROPE
Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 40: Europe Recent Past, Current & Future Analysis for Anticoccidial Drugs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 41: Europe 6-Year Perspective for Anticoccidial Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
TABLE 42: Europe Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 43: Europe 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
TABLE 44: Europe Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 45: Europe 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
TABLE 46: Europe Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 47: Europe 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
FRANCE
Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 48: France Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 49: France 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
TABLE 50: France Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 51: France 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
TABLE 52: France Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 53: France 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
GERMANY
Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 54: Germany Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 55: Germany 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
TABLE 56: Germany Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 57: Germany 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
TABLE 58: Germany Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 59: Germany 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
ITALY
TABLE 60: Italy Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 61: Italy 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
TABLE 62: Italy Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 63: Italy 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
TABLE 64: Italy Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 65: Italy 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
UNITED KINGDOM
Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 66: UK Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 67: UK 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
TABLE 68: UK Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 69: UK 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
TABLE 70: UK Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 71: UK 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
REST OF EUROPE
TABLE 72: Rest of Europe Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 73: Rest of Europe 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 75: Rest of Europe 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 77: Rest of Europe 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
ASIA-PACIFIC
Anticoccidial Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 78: Asia-Pacific Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 79: Asia-Pacific 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 81: Asia-Pacific 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 83: Asia-Pacific 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
REST OF WORLD
TABLE 84: Rest of World Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Class - Synthetic Drugs and Ionophore Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 85: Rest of World 6-Year Perspective for Anticoccidial Drugs by Drug Class - Percentage Breakdown of Value Sales for Synthetic Drugs and Ionophore Drugs for the Years 2025 & 2030
TABLE 86: Rest of World Recent Past, Current & Future Analysis for Anticoccidial Drugs by Drug Action - Coccidiostatic Action and Coccidiocidal Action - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 87: Rest of World 6-Year Perspective for Anticoccidial Drugs by Drug Action - Percentage Breakdown of Value Sales for Coccidiostatic Action and Coccidiocidal Action for the Years 2025 & 2030
TABLE 88: Rest of World Recent Past, Current & Future Analysis for Anticoccidial Drugs by Animal Type - Companion Animals and Livestock Animals - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 89: Rest of World 6-Year Perspective for Anticoccidial Drugs by Animal Type - Percentage Breakdown of Value Sales for Companion Animals and Livestock Animals for the Years 2025 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Biochem Pharmaceuticals
  • Boehringer Ingelheim Animal Health USA Inc.
  • Ceva Sante Animale
  • Elanco Animal Health Incorporated
  • HIPRA SA
  • Huvepharma
  • Impextraco NV
  • Merck & Co., Inc. - MSD Animal Health
  • Phibro Animal Health Corporation
  • Vetoquinol India Animal Health Pvt Ltd
  • VIRBAC Animal Health India Private Ltd.
  • Zoetis India Ltd

Table Information

Report AttributeDetails
No. of Pages162
PublishedJune 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 203.1 Million
Forecasted Market Value ( USD ) by 2030 $ 254.6 Million
Compound Annual Growth Rate3.8%
Regions CoveredGlobal

Related Topics

Related Reports

Anticoccidial Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Anticoccidial Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Anticoccidial Drugs Market Report 2025 - Product Image

Anticoccidial Drugs Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Feed Anticoccidials - Global Strategic Business Report - Product Image

Feed Anticoccidials - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Anticoccidial Drugs Market by End Use, Distribution Channel, Product Type, Form - Global Forecast to 2030 - Product Image

Anticoccidial Drugs Market by End Use, Distribution Channel, Product Type, Form - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From
Anticoccidial Drugs Market 2024-2028 - Product Image

Anticoccidial Drugs Market 2024-2028

  • Report
  • 139 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.